Literature DB >> 17629447

[POEMS syndrome].

Martin Soubrier1.   

Abstract

The POEMS syndrome combines a constant polyneuropathy (P), organomegaly (O), endocrinopathy (E), monoclonal gammopathy (M) (or other plasma cell disorder) and skin changes (S). Other manifestations may be observed: anasarca, fever, sweating, clubbed fingers, renal damage, arterial obstruction, pulmonary hypertension, thrombocytosis, and polycythemia. Its pathogenesis is not well elucidated but elevated levels of vascular endothelial growth factor (VEGF) appear to characterize it. Consistent plasma cell disorders include a monoclonal component, often in small quantities with a lambda light chain isotype, and plasmacytoma, often solitary lesions. Treatment depends on specific characteristics of the disease and the patient (radiation therapy for plasmocytoma, autologous bone marrow transplantation in young subjects, corticosteroid therapy or chemotherapy in the elderly). The usefulness of thalidomide and bevacuzimab in refractory POEMS syndromes remains to be seen.

Entities:  

Mesh:

Year:  2007        PMID: 17629447     DOI: 10.1016/j.lpm.2007.06.009

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome and Idiopathic Portal Hypertension: A Rare Association.

Authors:  Fatima Belabbes; Youssefi Houda; Abderahmane Al Bouzidi; Youssef Bennani; Maryame Ahnach
Journal:  Cureus       Date:  2022-05-11

2.  Missed diagnosis of POEMS syndrome with onset of progressive fatigue and numbness: a case report.

Authors:  Huan Shi; Xiaohong Jiang; Long Wang; Jiayan Zhou
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

3.  [POEMS syndrome: a diagnosis to not to ignore].

Authors:  Madiha Mahfoudhi; Sami Turki; Adel Kheder
Journal:  Pan Afr Med J       Date:  2015-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.